-
The time of day when a dose of immunochemotherapy is given in non-small cell lung cancer may have an impact on treatment efficacy.
Medical Mythbusting Commentary for February 17, 2026 Source:How well a cancer treatment works may depend on the time of day you get it Reference:Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
-
Radon gas may be giving more Canadians lung cancer. As a default, get your home, be it newly constructed or other, tested for radon gas.
Medical Mythbusting Commentary for January 28, 2026 Source:Radon gas may be giving more Canadians lung cancer. Scientists are racing to save lives Testing your home for radon
-
Radon gas detection tests recommended by Canadian Cancer Society
Madely Health Headlines Commentary for November 24, 2014 Source: Radon gas levels in homes need to be checked, lung cancer experts say
-
Overdiagnosis of lung cancer through CT screening does lead to harm for those whose cancers do not require treatment
Madely Health Headlines Commentary for December 10, 2013 [display_podcast] Source: Many lung cancer tumours prove harmless, study says Reference: Overdiagnosis in Screening for Lung Cancer Harms of Screening
-
New app helps determine risk of lung nodule malignancy potential
Madely Health Headlines Commentary for September 5, 2013 [display_podcast] Source: Lung cancer: Canadians develop app to predict if lesions are malignant Reference: Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
-
Lung cancer breath test is not designed for screening healthy people
Madely Health Headlines Commentary for December 16, 2011 [display_podcast] Source: Breath Test for Lung Cancer Shows Promise in New Study Reference: Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer
-
Targeted lung cancer therapy demonstrates how personalized medical therapy works
Madely Health Headlines Commentary for August 31, 2011 [display_podcast] Source: New Lung Cancer Pill Highlights Improved Way of Treating Patients Reference: Butrynski JE, et al “Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor” N Engl J Med2010; 363: 1727-1733.
-
Lung cancer incidence for women increasing while for men it is decreasing
Madely Health Headlines Commentary for June 8, 2010 [display_podcast] Source: Lung Cancer in Women on the Rise
-
New treatment classifications for lung cancer
An important factor that helps oncologists and surgeons decide whether aggressive chemotherapy and or surgery will be effective in treating cancerous tumours is a system of tumour classification. A recent overhaul to this system has opened new opportunities for thousands of patients with lung cancer previously classified as inoperable or beyond treatment. Dr. Peter Goldstraw,…